Clearpoint Neuro Inc
NASDAQ:CLPT
Clearpoint Neuro Inc
NASDAQ:CLPT
Price:
9.325
USD
2.47%
Market Cap:
$277.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
US |
|
Autins Group PLC
LSE:AUTG
|
UK |
|
M
|
MiniLuxe Holding Corp
XTSX:MNLX
|
CA |
|
H
|
Heeton Holdings Ltd
SWB:SST
|
SG |
|
T
|
Tharisa PLC
JSE:THA
|
CY |
|
Aeon Fantasy Co Ltd
TSE:4343
|
JP |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Hylink Digital Solutions Co Ltd
SSE:603825
|
CN |
|
Zhuhai Huafa Properties Co Ltd
SSE:600325
|
CN |
|
Commvault Systems Inc
NASDAQ:CVLT
|
US |
|
Enphase Energy Inc
NASDAQ:ENPH
|
US |
|
Telefonica SA
NYSE:TEF
|
ES |
|
Cannabix Technologies Inc
OTC:BLOZF
|
CA |
|
W
|
WindowMaster International A/S
F:9FF
|
DK |
Multiples-Based Value
The Multiples-Based Value of one
CLPT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 9.325 USD,
Clearpoint Neuro Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLPT Multiples-Based Value
LOCKED
Multiples Across Competitors
CLPT Competitors Multiples
Clearpoint Neuro Inc Competitors
Clearpoint Neuro Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
258.7m USD | 7.5 | -11.2 | -11.7 | -11.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.3B USD | 4 | 27.4 | 15.7 | 21.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
163.7B USD | 16.5 | 58 | 43.9 | 54 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 39 | 19.9 | 24.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.1B USD | 4.6 | 32.2 | 19.1 | 25.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.9B EUR | 1.8 | 19.5 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.5B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.8B USD | 10.4 | 42.4 | 30.1 | 33.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.4 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.7B USD | 6 | 21.9 | 15.4 | 17.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
